Tolerability of the dexamethasone-corticotropin releasing hormone test in major depressive disorder.
about
Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trialMetabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical Efficacy.Protocol for a randomised, double-blind, placebo-controlled trial to explore the effect of tramadol in the prevention of postpartum depression (ETPPD)
P2860
Tolerability of the dexamethasone-corticotropin releasing hormone test in major depressive disorder.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tolerability of the dexamethas ...... in major depressive disorder.
@ast
Tolerability of the dexamethas ...... in major depressive disorder.
@en
Tolerability of the dexamethas ...... in major depressive disorder.
@nl
type
label
Tolerability of the dexamethas ...... in major depressive disorder.
@ast
Tolerability of the dexamethas ...... in major depressive disorder.
@en
Tolerability of the dexamethas ...... in major depressive disorder.
@nl
prefLabel
Tolerability of the dexamethas ...... in major depressive disorder.
@ast
Tolerability of the dexamethas ...... in major depressive disorder.
@en
Tolerability of the dexamethas ...... in major depressive disorder.
@nl
P2093
P2860
P50
P1476
Tolerability of the dexamethas ...... in major depressive disorder.
@en
P2093
Charles B Nemeroff
Christine Heim
Elisabeth B Binder
Helen S Mayberg
Hildegard Pfister
Melissa McKenzie
Tanja Mletzko
W Edward Craighead
Yara Betancourt
P2860
P356
10.1016/J.JPSYCHIRES.2010.04.020
P577
2010-05-20T00:00:00Z